📰 Systemic Sclerosis News
Page 3 - Systemic Sclerosis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Systemic Sclerosis. Real-time updates on events, politics, business and more.
July 10, 2023
INSIDE INFORMATION Agreement with the main creditors of BioSenic for a standstill running until October 2023 Mont-Saint-Guibert, Belgium, July 10th, 2023, 7.00 am CEST – BIOSENIC ,...
June 30, 2023
INSIDE INFORMATION Launch of negotiation with main creditors Agreement with Global Tech Opportunities (GTO) to secure short term financing Mont-Saint-Guibert, Belgium, June 30, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in the areas of innate immunity, inflammation and organ/function repair, today provides a financial update. BioSenic has obtained an official appointment of Yves Brulard to reach a negotiated agr...
June 28, 2023
[228+ Pages Study] The global surgical tubing market size is estimated to grow USD 4200 million by 2030, at a CAGR of 8.0% between 2023 and 2030. The...
June 28, 2023
Nearly half of these patients had interstitial lung disease and had similar rates of scleroderma renal crisis, compared with the other disease subtypes.
June 26, 2023
NASHVILLE, Tenn., June 26, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the publication of positive results from a clinical study investigating the safety and pharmaco...
June 19, 2023
INSIDE INFORMATION Prior efficacy unmatched but excellent safety profile confirmed, timing of ALLOB administration for optimal bone repair to...
June 19, 2023
BioSenic puts Phase IIb ALLOB trial on hold.
June 5, 2023
The update to 2017 recommendations include targeted synthetic and biologic disease-modifying antirheumatic drugs for the first time.
June 2, 2023
/PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of...
June 1, 2023
Information on the total number of voting rights and shares Mont-Saint-Guibert, Belgium, June 1, 2023, – BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in in the areas of innate immunity, inflammation and organ/function repair, today announces an increa...